Please assess the completion status of the following clinical trial:

Trial Title: Prevention of Unexplained Recurrent Abortion by Enoxaparine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women between 18 and 45 years~* 2 or more consecutive spontaneous abortions before the 15th week of pregnancy~* Unexplained abortions~* No maternal or paternal characterized chromosomal aberration~* No Anti-phospholipid Syndrome~* No anatomical abnormality possibly responsible for abortion~* No Factor V Leiden~* No Prothrombin G20210A mutation~* No protein S deficiency~* No protein C deficiency~* No Anti thrombin 3 deficiency~* Proved pregnancy~Exclusion Criteria:~* Contraindications of enoxaparine 4000 U per day~* Women with risk of venous thromboembolism during pregnancy~* No regular anticoagulation or antiplatelet treatment~* Blood Hemoglobin level below 10g/dl~* Blood platelet level below 150 000/mm3~* Creatinine clearance below 30ml/mn~* Anomaly of the coagulation tests~* No informed consent

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- 2 (Type: PLACEBO_COMPARATOR): None
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).